INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $358,218 | +131.1% | 26,673 | +137.8% | 0.12% | +51.9% |
| Q2 2022 | $155,000 | -52.5% | 11,216 | +173.6% | 0.08% | -64.5% |
| Q2 2019 | $326,000 | -71.8% | 4,099 | -79.3% | 0.22% | -35.8% |
| Q4 2017 | $1,156,000 | +123.6% | 19,786 | +122.3% | 0.34% | +131.5% |
| Q3 2017 | $517,000 | -28.8% | 8,900 | +48.3% | 0.15% | -41.8% |
| Q2 2017 | $726,000 | +64.6% | 6,000 | +53.8% | 0.25% | +39.4% |
| Q1 2017 | $441,000 | – | 3,900 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |